
Viveve Medical VIVE
Quarterly report 2022-Q3
added 11-10-2022
Viveve Medical DSO Ratio 2011-2026 | VIVE
Annual DSO Ratio Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 37.5 | 51.3 | 87.4 | 112 | 148 | 107 | 150 | 24.3 | 144 | 136 | 246 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 246 | 24.3 | 113 |
Quarterly DSO Ratio Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 45 | 33.3 | 29.4 | - | 34.2 | 28.5 | 34.8 | - | 46.1 | 99.8 | 82 | - | 136 | 136 | 110 | - | 108 | 94.2 | 147 | - | 139 | 184 | 125 | - | 103 | 123 | 95.4 | - | 92.7 | 741 | 719 | - | 32.2 | 7.5 | 493 | - | 6.91 K | 87.3 | 119 | - | 173 | 101 | 1.95 K | - | 1.53 K | 104 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.91 K | 7.5 | 428 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
40.7 | $ 28.6 | -1.92 % | $ 1.32 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 12.19 | -3.02 % | $ 1.83 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 36.62 | -4.9 % | $ 5.46 K | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 8.63 | 2.92 % | $ 620 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 9.51 | -0.94 % | $ 1.29 B | ||
|
Electromed
ELMD
|
137 | $ 24.0 | -1.56 % | $ 203 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 40.21 | -2.9 % | $ 1.25 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.21 | -0.94 % | $ 157 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.16 | -3.07 % | $ 109 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.48 | -0.48 % | $ 121 M | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.49 | -2.39 % | $ 50.4 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.82 | 1.35 % | $ 44.6 M | ||
|
Align Technology
ALGN
|
86.7 | $ 173.34 | -1.29 % | $ 13 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 3.65 | -2.93 % | $ 773 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 109.92 | -0.95 % | $ 191 B | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 98.53 | -1.57 % | $ 1.25 B | ||
|
Inogen
INGN
|
35.8 | $ 6.46 | -1.37 % | $ 172 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 13.26 | -1.45 % | $ 857 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 71.46 | -2.09 % | $ 106 B | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 18.05 | 1.29 % | $ 423 M | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.24 | -10.14 % | $ 20 M | ||
|
Pulmonx Corporation
LUNG
|
54.9 | $ 2.03 | 25.78 % | $ 79.4 M | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 2.17 | -3.55 % | $ 1.32 M | ||
|
Medtronic PLC
MDT
|
68.8 | $ 90.96 | -2.2 % | $ 117 B | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 82.03 | -2.21 % | $ 48 B |